NIH Federal Register Notice of Invention Licensing Opportunity, Feb. 13, 1996

NIH Federal Register Notice of Invention Licensing Opportunity, released Feb. 13, 1996

National Institutes Of Health

Government-Owned Inventions; Notice of Availability for Licensing

AGENCY: National Institutes of Health, Public Health Service, DHHS

ACTION: Notice

SUMMARY: The invention listed below is owned by the Department of Health and
Human Services and is available for licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious commercialization of results of
federally-funded research and development.
U.S. Patent 4,405,712, issued on September 20, 1983 and entitled "LTR
Vectors" -- This patent broadly claims processes of obtaining the expression
of any gene via the use of retroviral expression vectors containing long
terminal repeat (LTR) sequences. The processes claimed in this patent are of
fundamental significance for the retroviral mediated expression of genes in
vitro for research and biopharmaceutical production and in vivo for research,
biopharmaceutical production, and therapeutic applications such as somatic
cell gene therapy. The invention claimed in this patent is available for
licensing on a nonexclusive basis.
Favorable licensing terms will be offered to companies filing a license
application within three months of the publication of this notice. After that
deadline (May 13, 1996), licensing fees will be increased.

ADDRESS: Licensing information may be obtained by writing to: George H.
Keller, Ph.D., Office of Technology Transfer, National Institutes of Health,
6011 Executive Boulevard, Suite 325, Rockville, MD 20852-3804 (telephone
301/496-7057; fax: 301/402-0220).
Published in the Federal Register on Tuesday, February 13, 1996 [61 FR 5565]